Prospective Observation of the Incidence and Natural History of Monoclonal Gammopathy in Patients Undergoing Weight Reduction Surgery
The purpose of this study is to find out whether there is a relationship between weight and monoclonal gammopathy of undetermined significance (MGUS).
The purpose of this study is to observe the incidence of MGUS among obese patients planning to have weight reduction surgery or who plan to enter a physician monitored weight loss program and to follow the regression or progression of MGUS following surgery or the initiation of the weight loss program.
- IRB Number: 1805432228 (IUSCC-0633)
- Research Study Identifier: TX8874
- Principal Investigator: Rafat Abonour, MD
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required